| Latest | F'cast | |
|---|---|---|
| Div Yield | 0.0% | |
| Div Cover | n/a | |
| Op Mrgn | -2818.9% | |
| ROCE | 4.4% |
| Latest | F'cast | |
|---|---|---|
| P/E | 7.9 | |
| PEG | n/a | |
| Pr/Revenue | 82.0 | |
| Pr/Book | 1.0 |
| Latest | F'cast | |
|---|---|---|
| Revenue | 45.0% | |
| PBT | n/a | |
| EPS | n/a | |
| DPS | n/a |
| Year Ending | Revenue ($m) | Pre-tax ($m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-20 | 11.77 | 18.97 | 2.00¢ | 260.0 | n/a | -99% | n/a | 0.0% |
| 31-Dec-21 | 17.39 | (58.95) | (21.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-22 | 15.62 | (92.78) | (18.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-23 | 3.33 | (36.10) | (24.00)¢ | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-24 | 4.83 | 23.77 | 21.00¢ | 9.4 | n/a | n/a | n/a | 0.0% |
| Year Ending | Revenue (£m) | Pre-tax (£m) | EPS | P/E | PEG | EPS Grth. | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 31-Dec-25 | n/a | (144.20) | (45.63)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-26 | n/a | (154.30) | (49.43)p | n/a | n/a | n/a | n/a | 0.0% |
| 31-Dec-27 | n/a | (165.30) | (52.47)p | n/a | n/a | n/a | n/a | 0.0% |
Copyright © 2025 FactSet Research Systems Inc. All rights reserved.
| Invesco Ltd: Form 8.3 - PureTech Health PLC; Ope... | 08-Apr-2025 | 14:53 | GlobeNewswire NA |
| Form 8.3 - The Vanguard Group, Inc.: PureTech He... | 08-Apr-2025 | 14:48 | EQS Group |
| Form 8.3 - [PURETECH HEALTH PLC - Opening Disclo... | 08-Apr-2025 | 11:40 | GlobeNewswire NA |
No deals were found in the last 28 days.
| Currency | UK Pounds |
| Share Price | 128.00p |
| Change Today | -0.010p |
| % Change | -0.78 % |
| 52 Week High | 173.60 |
| 52 Week Low | 101.60 |
| Volume | 129,631 |
| Shares Issued | 237.39m |
| Market Cap | £303.86m |
| Strong Buy | 1 |
| Buy | 0 |
| Neutral | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 1 |

| Time | Volume / Share Price |
| 16:27 | 1,071 @ 128.00p |
| 16:27 | 346 @ 128.00p |
| 16:19 | 1,950 @ 127.80p |
| 16:17 | 448 @ 127.60p |
| 16:17 | 11 @ 127.60p |
You are here: research